METTL3 and glioblastoma: Furthermore, MeRIP-qPCR assays demonstrated that WEE2-AS1 could be significantly enriched by an m6A antibody, enrichment of which was significantly downregulated in METTL3-knockdown GBM cells compared with the NC group (Figure 3C and Figure S4A).